Myonex completed the acquisition of the pharmaceutical services business from Creapharm.

Myonex, a clinical trial supply company, completed the acquisition of the pharmaceutical services business from Creapharm, a clinical trial supply management company. Financial terms were not disclosed. "We are thrilled to have completed the acquisition of Creapharm, a milestone that expands our services and enhances our capabilities for clients and the industry. Together, we are poised to meet the dynamic needs of our clients with agility, flexibility, and reliability," James Lovett, Myonex CEO.